Observational
Time Perspective: Prospective
identify specific biomarkers to more accurately characterize malignant cells in metastatic pleural disease
Research for quantitative or qualitative nuclear-matrix-proteins anomalies in secondary metastatic pleural disease and/or for anomalies in the genes coding for these proteins. Protein analysis : immunofluorenscy, western blot. Genomic analysis : CGH arrays.
2 years
No
Patrice Roll
Principal Investigator
Assistance Publique des Hôpitaux de Marseille
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
2010-A00295-34
NCT01284777
May 2010
Name | Location |
---|